Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0002009141-24-000001·Bellerophon Therapeutics, Inc.
Schedule 13G ownership disclosure
BELLEROPHON THERAPEUTICS INC
Common Stock, par value $0.01 per share · CUSIP: 078771300
Event date: 2024-01-16
- Filing-level shares
- 642,844.00
- Percent of class
- 5.3%
- Nelson Michael Aaron
Shares: 642,844.00 · Class: 5.3%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0002009141-24-000001
- Form type
- SCHEDULE 13G
- Filer
- Bellerophon Therapeutics, Inc.
- CIK
- CIK 1600132
- Filed
- Jan 26, 2024
- Reporting period
- Jan 16, 2024
- Description
- Schedule 13G beneficial ownership